Department of Regenerative Medicine, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Yokohama, Kanagawa 236-0004, Japan.
Biomaterials. 2013 Jul;34(23):5785-91. doi: 10.1016/j.biomaterials.2013.04.003. Epub 2013 May 2.
Islet transplantation can induce a substantial improvement in the treatment of type 1 diabetes mellitus. However, the clinical application of islet transplantation is severely limited by the shortage of donor organs. It is thus essential to improve the engraftment rate to achieve the expected outcome in the treatment of diabetes mellitus using a limited amount of donor islets. In this manuscript, we describe the generation of β-cell spheroids using mouse insulinoma cells (MIN6) as a model of β-cells. We established a 3D culture system that simulates microgravity using a 3D clinostat. Using this method, we were able to produce 100 spheroids per mL of culture media. The optimization of the culture conditions in the clinostat produced spheroids with a size of approximately 250 μm, which is a size that is known to induce good graft survival after islet transplantation. The spheroids produced in the clinostat expressed several β-cell signature genes at higher levels than the levels that were found in MIN6 cells that were cultured in a standard 2D culture dish (MIN6-2D). The transplantation of the spheroids into the portal vein of streptozotocin-induced diabetic mice ameliorates hyperglycemia, whereas the transplantation of the equivalent number of 2D-cultured cells failed to cure diabetes. These results indicate that the clinostat culture provides a new method for the reconstitution of a large number of functional β-cell spheroids for diabetes treatment.
胰岛移植可以显著改善 1 型糖尿病的治疗效果。然而,由于供体器官短缺,胰岛移植的临床应用受到严重限制。因此,有必要提高胰岛的移植效率,从而在利用有限数量的供体胰岛治疗糖尿病方面实现预期效果。在本文中,我们描述了使用小鼠胰岛素瘤细胞(MIN6)作为β细胞模型生成β细胞球体的方法。我们建立了一个 3D 培养系统,使用 3D 回旋器模拟微重力。使用这种方法,我们能够在每毫升培养基中产生 100 个球体。在回旋器中优化培养条件可以产生直径约为 250μm 的球体,这种大小已知在胰岛移植后能诱导良好的移植物存活。与在标准 2D 培养皿中培养的 MIN6 细胞(MIN6-2D)相比,回旋器中培养的球体表达了几种β细胞特征基因,表达水平更高。将球体移植到链脲佐菌素诱导的糖尿病小鼠门静脉中可以改善高血糖,而移植等量的 2D 培养细胞则不能治愈糖尿病。这些结果表明,回旋器培养为治疗糖尿病提供了一种新的方法,可以大量重建功能性β细胞球体。